H
Herman Mielants
Researcher at Ghent University Hospital
Publications - 239
Citations - 19352
Herman Mielants is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Ankylosing spondylitis & Arthritis. The author has an hindex of 63, co-authored 239 publications receiving 17682 citations. Previous affiliations of Herman Mielants include University of Liège & Ghent University.
Papers
More filters
Journal ArticleDOI
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
K. Visser,Wanruchada Katchamart,Estíbaliz Loza,Juan Antonio Martínez-López,Carine Salliot,Judith Trudeau,Claire Bombardier,Loreto Carmona,D. van der Heijde,Johannes W. J. Bijlsma,Dimitrios T. Boumpas,Helena Canhão,Christopher J Edwards,Hamuryudan,Tore K Kvien,Burkhard F. Leeb,Emilio Martín-Mola,Herman Mielants,Ulf Müller-Ladner,G Murphy,Mikkel Østergaard,Ivanio Alves Pereira,Cesar Ramos-Remus,Gabriele Valentini,Jane Zochling,Maxime Dougados +25 more
TL;DR: In the 3E (Evidence, Expertise, Exchange) Initiative of 2007-8, 751 rheumatologists from 17 countries participated in three separate rounds of discussions and Delphi votes as mentioned in this paper.
Journal ArticleDOI
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter.
Astrid J. B. Wanders,Robert Landewé,Anneke Spoorenberg,Maxime Dougados,Sjef van der Linden,Herman Mielants,Hille van der Tempel,Désirée van der Heijde +7 more
TL;DR: The M-SASSS is the most appropriate method by which to score the radiographic progression in AS patients in clinical trials and is found that the highest percentage of patients with a change >0.
Journal ArticleDOI
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.
Filip Van den Bosch,Elli Kruithof,Dominique Baeten,Annemie Herssens,Filip De Keyser,Herman Mielants,Eric Veys +6 more
TL;DR: Tumor necrosis factor alpha blockade with infliximab in patients with active SpA was well tolerated and resulted in significant clinical and laboratory improvements in this short-term, placebo-controlled study.
Journal ArticleDOI
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
L De Rycke,I Peene,Ilse Hoffman,Elli Kruithof,Ann Union,Lydie Meheus,K. Lebeer,Bart Wyns,Christian Vincent,Herman Mielants,Luc Boullart,Guy Serre,E M Veys,F De Keyser +13 more
TL;DR: The presence of RA associated antibodies and the SE are indicative for poorer radiological outcome, and presence of extra-articular manifestations is associated with RF but not with anticitrullinated protein antibodies.
Journal Article
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Anneke Spoorenberg,D. van der Heijde,E de Klerk,Maxime Dougados,K. de Vlam,Herman Mielants,H van der Tempel,S van der Linden +7 more
TL;DR: It is concluded that neither CRP nor ESR is superior to assess disease activity, and the positive predictive values of CRP and ESR in the setting were low.